Skip to content

A Study on the effect of appropriate use of Rasayana Churna Vati and Haritaki Churna in post Covid 19 Pandemic.

An Exploratory Clinical Study to evaluate the efficacy of appropriate restorative intervention (Vidhivat Rasayana Upyog) in context of Pandemic (Janapadodhwamsa) with Haritaki Churna and Rasayana Churna Vati in Post Covid 19 management.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/046980
Enrollment
60
Registered
2022-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system Health Condition 2: J00-J99- Diseases of the respiratory system

Interventions

None listed

Sponsors

All India Institute of Ayurveda, Sarita Vihar, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects who have recovered from COVID-19 (RTPCR - negative) having history of mild, moderate, severe infection will be included in the study with persistence of symptoms or development of general sequelae (fatigue, joint pain, muscular pain and fever) beyond 3 or 4â??weeks from the onset of acute symptoms of COVID-19 2.Subjects without any bar of race, religion and gender.

Exclusion criteria

Exclusion criteria: 1.Patient less than 21 yrs. and above 60yrs. of age will be excluded. 2.The pregnant women and lactating mother will be excluded. 3.Patients who have completed participation in any other clinical trial during the past six months. 4.Patients with co-morbidities like Chronic Obstructive Pulmonary disease (COPD), Ischemic Heart Disease (IHD), Chronic Kidney Disease (CKD), coagulopathy and cancer. 5.Patients who were on immuno-suppressant, oral steroids or chemotherapy. 6.Patients k/c/o Diabetes Mellitus (DM) taking insulin.

Design outcomes

Primary

MeasureTime frame
Significant relief in symptoms of post COVID 19 in general sequelae. (Aartasya Rognut effect of Rasyana Churan Vati will be expected )Timepoint: 4 weeks

Secondary

MeasureTime frame
Improvement in Quality of LifeTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Kamal Kumar

All India Institute of Ayurveda, Sarita Vihar, New Delhi

kamalkumar324@gmail.com9785031320

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026